Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.16B | 4.32B | 4.04B | 3.62B | 3.10B |
Gross Profit | 2.90B | 3.01B | 2.85B | 2.48B | 1.94B |
EBITDA | -411.40M | 33.27M | 73.90M | 47.05M | -509.00M |
Net Income | -467.94M | -32.84M | 44.18M | 39.97M | -500.50M |
Balance Sheet | |||||
Total Assets | 3.32B | 3.98B | 4.81B | 5.00B | 4.89B |
Cash, Cash Equivalents and Short-Term Investments | 1.98B | 2.12B | 3.03B | 3.40B | 3.49B |
Total Debt | 3.99M | 7.94M | 11.85M | 15.72M | 19.54M |
Total Liabilities | 548.21M | 653.73M | 596.75M | 638.81M | 569.47M |
Stockholders Equity | 2.77B | 3.33B | 4.21B | 4.36B | 4.32B |
Cash Flow | |||||
Free Cash Flow | 80.93M | 73.78M | -156.36M | -103.19M | -502.94M |
Operating Cash Flow | 97.95M | 168.08M | 23.57M | 123.62M | -437.53M |
Investing Cash Flow | -146.28M | -163.88M | -206.38M | -209.99M | -51.54M |
Financing Cash Flow | -98.94M | -919.63M | -185.52M | -4.81M | -187.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥4.51B | 18.91 | 5.79% | -3.72% | -33.00% | ||
72 Outperform | ¥3.95B | 9.72 | 2.65% | -0.71% | -12.08% | ||
69 Neutral | ¥4.56B | 16.61 | 1.84% | 7.15% | -27.20% | ||
60 Neutral | €3.16B | -11.01 | 44.79% | 7.74% | -4.42% | 21.19% | |
60 Neutral | ¥1.80B | ― | ― | 0.82% | -121.69% | ||
58 Neutral | ¥3.75B | 147.74 | 3.14% | 0.09% | -848.16% | ||
52 Neutral | ¥2.96B | ― | ― | 13.28% | 41.92% |